The Journal of Neuroscience, July 9, 2003, 23(14):6086-6095
Previous Article | Next Article 
Presynaptic Depression of Glutamatergic Synaptic Transmission by D1-Like Dopamine Receptor Activation in the Avian Basal Ganglia
Long Ding,2
David J. Perkel,1 and
Michael A. Farries1
1Departments of Biology and Otolaryngology,
University of Washington, Seattle, Washington 98195-6515, and
2Department of Neuroscience, University of
Pennsylvania, Philadelphia, Pennsylvania 19104
 |
Abstract
|
|---|
Vocal behavior in songbirds exemplifies a rich integration of motor,
cognitive, and social functions that are shared among vertebrates. As a part
of the underlying neural substrate, the song system, the anterior forebrain
pathway (AFP) is required for song learning and maintenance. The AFP resembles
the mammalian basal gangliathalamocortical loop in its macroscopic
organization, neuronal intrinsic properties, and microcircuitry. Area X, the
first station in the AFP, is a part of the basal ganglia essential for vocal
learning. It receives glutamatergic inputs from pallial structures and sends
GABAergic outputs to thalamic structures. It also receives dense dopaminergic
innervation from the midbrain. The role of this innervation is essentially
unknown. Here we provide evidence that dopamine (DA) can modulate the
glutamatergic inputs to spiny neurons in area X. In whole-cell voltage-clamp
recordings from neurons in brain slices of adult zebra finches, we found that
activation of D1-like DA receptors depresses ionotropic glutamatergic synaptic
current in area X spiny neurons. This effect is mediated by a presynaptic site
of action, mimicked by activation of adenylyl cyclase, and blocked by protein
kinase A inhibitor and an adenosine A1 receptor antagonist. These results
suggest that, in addition to altering the inputoutput function of spiny
neurons by modulating their excitability, as we have shown previously, DA can
directly influence the excitatory inputs to these neurons as well. Thus, DA
can exert fine control over information processing through spiny neurons in
area X, the dynamics of the AFP output, and ultimately song learning and
maintenance.
Key words: dopamine; basal ganglia; songbird; synaptic transmission; area X; vocal learning
 |
Introduction
|
|---|
Birdsong has been a good model for studies of sensorimotor learning,
perceptual learning, hormonal control, and neurogenesis in vertebrates. In the
underlying neural circuit, the song system (see
Fig. 1), the anterior forebrain
pathway is essential for song learning and maintenance but not for song
production (Bottjer et al.,
1984
; Sohrabji et al.,
1990
; Scharff and Nottebohm,
1991
; Brainard and Doupe,
2000
). The first station of the anterior forebrain pathway is area
X, a part of the avian basal ganglia that is specialized for song-related
behaviors.

View larger version (29K):
[in this window]
[in a new window]
|
Figure 1. A simplified diagram of the oscine song system. The song system consists of
three major pathways. The nucleus interfacialis (NIf) likely provides key
auditory input to the song system. The motor pathway starts with nucleus HVC
(used as a proper name). HVC projects to the robust nucleus of archistriatum
(RA), which innervates several brainstem nuclei controlling respiration and
vocalization. The anterior forebrain pathway starts with the projection from
HVC to area X, a part of the avian basal ganglia within the lobus
parolfactorius (LPO). Area X projects to the medial portion of the
dorsolateral nucleus of the anterior thalamus (DLM), which sends its output to
the lateral magnocellular nucleus of the anterior neostriatum (LMAN), which
projects to RA and sends collaterals to area X. Area X thus receives
glutamatergic inputs from HVC and LMAN. It also receives dense dopaminergic
inputs from the ventral area of Tsai (AVT). The gray area represents the
paleostriatal complex.
|
|
Area X is strikingly similar to mammalian basal ganglia in its
cytoarchitecture, synaptic circuitry, neurochemistry, and topographic
organization (Vates and Nottebohm,
1995
; Bottjer and Johnson,
1997
; Reiner et al.,
1998
; Luo et al.,
2001
). In addition, spiny neurons (SNs) in area X show close
resemblance in their intrinsic properties to the mammalian striatal medium
spiny projection neuron (Farries and
Perkel, 2002
). Both cell types receive glutamatergic inputs from
pallial structures (Farries,
2002
) and dense dopaminergic innervation from midbrain nuclei
(Lewis et al., 1981
;
Bottjer, 1993
;
Soha et al., 1996
).
Dopaminergic inputs to the basal ganglia play important roles in motor and
cognitive functions in mammals (Graybiel
et al., 1994
; Brown et al.,
1997
; Schultz,
1998
). The neural basis for these broad-ranged behavioral effects
has been under extensive study. The role of dopamine (DA) in singing behavior
is still unknown, and there have been few reports on the physiological actions
of DA in the avian basal ganglia. However, the tractable singing behavior and
the discrete underlying neural circuits in songbirds provide an excellent
model system for elucidating the neural basis of DA functions in vertebrates
in general.
We demonstrated previously that DA modulates excitability in spiny neurons
(SNs) in area X, suggesting that DA can indeed influence information
processing in the song system by altering the inputoutput functions of
SNs (Ding and Perkel, 2002
).
Here we report that D1-like DA receptor activation suppresses glutamatergic
synaptic responses in SNs in area X of adult zebra finches. The suppression is
blocked by an inhibitor of protein kinase A (PKA) and an adenosine receptor
antagonist and requires a presynaptic site of action. These new results
suggest that DA can further shape the output of area X by direct modulation of
its excitatory inputs, thus exerting fine control over the dynamics of the
anterior forebrain pathway and ultimately the singing behavior.
 |
Materials and Methods
|
|---|
Slice preparation. Adult male zebra finches (Taeniopygia
guttata), obtained from two suppliers, were kept in groups of five or
fewer on a 13/11 hr light/dark cycle. Slicing procedures were as described by
Stark and Perkel (1999
) and
were approved by the Institutional Animal Care and Use Committee at the
University of Washington. Briefly, a bird was anesthetized with isoflurane and
decapitated. The brain was quickly removed and immersed in ice-cold artificial
CSF (ACSF) containing (in mM): 119 NaCl, 2.5 KCl, 1.3
MgSO4, 2.5 CaCl2, 1 NaH2PO4, 16.2
NaHCO3, 11 D-glucose, and 10 HEPES, osmolarity
288298 mOsm. Coronal or parasagittal slices were cut at 300400
µm thickness with a Vibratome 1000 Plus (Vibratome, St. Louis, MO) in
ice-cold ACSF and then transferred to a storage chamber containing ACSF heated
to 3035°C. The storage chamber was allowed to cool to room
temperature after slicing was completed. In both the storage and recording
ACSF, HEPES was replaced with equi-osmolar NaHCO3. All solutions
were bubbled with a 95% O2 and 5% CO2 mixture.
Electrophysiological recordings. Recordings started at least 1 hr
after slicing was completed. A slice was transferred to a small recording
chamber perfused (flow rate: 23 ml/min) with the HEPES-free ACSF
containing 150 µM picrotoxin (Sigma, St. Louis, MO), osmolarity
290310 mOsm. All recordings were made at room temperature. When
trans-illuminated, area X is visually identifiable as a dark region in the
paleostriatal complex ventral to the lamina medullaris dorsalis. Neurons in
area X were recorded using the "blind" whole-cell technique
(Blanton et al., 1989
) in
voltage-clamp mode. Glass pipettes were pulled to have a tip of <2 µm in
diameter (Micropipette puller P-97, Sutters Instrument Co., Novato, CA).
Pipettes were filled with internal solution containing (in mM): 120
Cs-gluconate, 10 HEPES, 0.2 EGTA, 8 NaCl, 2 ATP, 0.3 GTP, 2 MgCl2,
5 QX-314, 10 phosphocreatine, and 1017 biocytin, pH 7.257.35,
osmolarity 288300 mOsm. In some cases, 100400 µM
Rpadenosine 3',5'-cyclic monophosphorothioate (Rp-cAMPS) (Tocris,
Ellisville, MO) was also added to the internal solution. The electrode
resistance ranged from 6 to 10 M
. Signals were first amplified with an
Axopatch 2D (Axon Instruments, Foster City, CA) and then low-pass filtered (5
kHz, unless noted otherwise) and further amplified with a Brownlee Model 410
amplifier (Brownlee Precision, Santa Clara, CA). The filtered signals were
digitized (10 kHz, unless noted otherwise) with a National Instruments
(Austin, TX) digitizing board and stored in a PC using a custom data
acquisition program written in LabView (National Instruments) by M. A. Farries
and D. J. Perkel.
Cell type identification. In area X
(Fig. 1), both SNs and aspiny
fast firing neurons receive glutamatergic inputs
(Farries, 2002
). Little
knowledge exists of glutamatergic inputs to the other interneuron cell types.
Because we used a cesium-based internal solution with QX-314 to obtain better
voltage-clamp recordings, it was not possible to identify SNs using the common
criteria such as inward rectification or delayed firing in current-clamp mode.
Instead, we based our neuron identification on the following properties: (1)
spontaneous activity (we observed whether the cell was spontaneously active
during tight-seal formation); (2) resting potential (we recorded the resting
potential immediately after gaining access to the cell); (3) intrinsic
properties [after the cell was clamped at a holding potential of -80 mV, we
monitored its response to a symmetric voltage ramp (from -80 to 0 mV and back
in 600 msec; see Fig. 2
A, inset)]; (4) morphology (we attempted to reconstruct
each cell histologically after experiments were completed; see below). The
first two properties were monitored because in comparison with other cell
types in area X, the SN is not spontaneously active and has a more
hyperpolarized resting membrane potential
(Farries and Perkel, 2002
).
The current response to the voltage ramp displays distinct profiles (see
Results) that procedurally facilitate on-line cell identification.

View larger version (94K):
[in this window]
[in a new window]
|
Figure 2. Classification of spiny versus nonspiny neurons in area X.
A1, A micrograph of a spiny neuron recovered
histologically after recording. Scale bar, 20 µm.
A2, A spiny dendrite of the same cell viewed at
higher magnification. Scale bar, 10 µm. A3,
The response of this cell to the standard voltage ramp. Note the prominent
double-peaked inward current. Calibration:vertical 500 pA, horizontal 100
msec. B1, A micrograph of a nonspiny neuron; same
scale as A1. Note the larger soma and
different shape of dendritic branches, compared with
A1. B2, The dendrite
of this cell is beady but not spiny; same scale as
A2. B3, The ramp
response. Note the large outward current after the early inward peak.
Calibration: vertical 500 pA, horizontal 100 msec. C, Scatter-plot of
the initial resting potential and ramp index calculated from the ramp
response. Filled circles represent cells used in this paper; filled triangles
represent cells that were spontaneously active before patching; open circles
represent other cells recorded. Note the two distinct clusters and the large
proportion of cells in the left cluster. D, Scatter-plot of the soma
diameter and ramp index from all cells reconstructed histologically.
|
|
Synaptic physiology. EPSCs were evoked at >15 sec intertrial
intervals by electrical stimulation with bipolar stainless-steel electrodes.
The stimulating electrodes were placed either in area X or, to distinguish the
inputs from HVC (used as a proper name) versus the lateral magnocellular
nucleus of the anterior neostriatum (LMAN), near the boundary of area X in
coronal sections as shown in Figure
3A, on the basis of a previous description of innervation
patterns (Bottjer et al.,
1989
). Recording pipettes (data not shown) were placed near and
ventral to the stimulating electrodes in most cases. The spatial relationship
between the stimulating and recording electrodes in the other axes varied.

View larger version (19K):
[in this window]
[in a new window]
|
Figure 3. A, Illustration of a coronal section through area X and placement
of stimulating electrodes. B, Pharmacological and temporal isolation
of NMDA and non-NMDA receptor-mediated EPSCs. EPSCs were evoked at holding
potentials of +50 and -80 mV. Arrows indicate the time points when early and
late components of the EPSC were measured.
|
|
Putative monosynaptic EPSCs were identified by their short and stable
latency and in some cases by their ability to follow high-frequency stimulus
trains up to 50 Hz. NMDA and non-NMDA ionotropic (non-NMDA) glutamate
receptor-mediated EPSCs were assessed at holding potentials of depolarized
values (more than or equal to -40 mV) and -80 mV, respectively (see
Fig. 3B). Throughout
all experiments, input resistance and series resistance were monitored with a
-10 mV, 250 msec voltage pulse. Paired-pulse stimuli at 3050 msec
intervals were delivered to test for possible involvement of presynaptic sites
of action. In some cases, postsynaptic NMDA receptor function was assessed
directly by picoliter pressure application of NMDA (Tocris) with a Pressure
System IIe (Toohey Company, Fairfield, NJ). In these experiments, signals were
low-pass filtered at a cutoff frequency of 13 kHz and digitized at
twice the filter frequency. Other drugs used include R-(+)-SKF-38393
hydrochloride, forskolin, 1,9-dideoxyforskolin, (R)(+)-SCH-23390
hydrochloride, DA (Sigma), sulpiride, Rp-cAMPS, 3-aminopropyl diethoxymethyl
phosphinic acid (CGP35348),
N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide
(AM251), 8-cyclopentyl-1,3-dipropylxanthine (DPCPX),
6-cyano-7-nitro-quinoxaline-2,3-dione (CNQX), and
D(-)-2-amino-5-phosphonopentanoic acid(D-APV)(Tocris).
Forskolin, sulpiride, DPCPX, and AM251 stock solutions were prepared in
dimethyl sulfoxide (DMSO; Fisher Scientific, Fair Lawn, NJ). Stock solutions
of 1,9-dideoxyforskolin and SCH-23390 were prepared in 100% ethanol. CNQX was
first dissolved in 0.1N NaOH or DMSO. Other stock solutions were prepared
indeionized water. Unless specified otherwise, all drugs were diluted 1:1000
in picrotoxin-containing ACSF and bath applied.
Data analysis. To quantify the ramp response, the linear portion
of the response curve (i.e., the portion mediated by passive conductance) was
first estimated by averaging data points between 100 and 150 msec after the
onset of the ramp. The ramp index was computed as the charge under the curve
between the onset of the ramp and 400 msec after, from which the linear
portion was deducted. Intuitively, the ramp index captures the balance between
inward and outward currents mediated by voltage-dependent conductances.
In most cases, the size of non-NMDA receptor-mediated EPSCs (EPSC size) was
measured at the minimum point after the stimulus. In experiments in which drug
application reduced the EPSC such that the stimulus artifact prevented
identification of the minimum point, we measured the latency to the minimum
point from traces recorded before drug application. We then measured EPSC size
using a 1 msec window average at this latency for all traces. The size of NMDA
receptor-mediated EPSCs (late EPSC size) was measured at 2949 msec
after stimulus onset, depending on the presence/interval of a subsequent
stimulus pulse (see Fig.
3B). A constant latency was used for each experiment. In
cases in which a pulse pair was delivered, the second late EPSC size was
measured as the difference between the absolute current value at the specified
latency and the value extrapolated from the first EPSC using a
single-exponential fit. Paired-pulse ratio was calculated as the ratio of the
second EPSC size to the first. The percentage change induced by drug
application was calculated as (value with drug - value before drug)/value
before drug, expressed in percentage, in which each value was an average from
10 iterations in most experiments. "Value before drug" was
measured immediately before the onset of drug entry. "Value with
drug" was measured 710 min after the onset of drug entry. In
experiments using pressure application of NMDA, the peak amplitude of response
to each puff was measured. The percentage change was calculated as described
above except that only three to five values were averaged. This is because the
response to NMDA puff was substantially longer than that to electrical
stimulation, which led to fewer samples within the same sampling period.
Experiments were excluded from further analysis if there was >20% increase
in the series resistance. Also excluded were cells with unstable responses
before drug applications. Statistical results were obtained using internal
functions in Prism 3.0 (GraphPad Software Inc., San Diego, CA). For multiple
comparisons of the percentage change in EPSC size, the KruskalWallis
test was used, followed by Dunn's multiple comparison test. Each example trace
is an average of five consecutive raw traces, unless specified otherwise.
Histological procedures. After an experiment was completed, the
slice was fixed in paraformaldehyde (4% in 0.1 M phosphate buffer)
overnight at 4°C and transferred to a sucrose solution (30% sucrose in 0.1
M phosphate buffer) for cryoprotection. After at least overnight
immersion in the sucrose solution at 4°C, slices were sectioned to 50
µm thickness with a freezing microtome. Resectioned slices were processed
with an avidinbiotinhorseradish peroxidase complex kit, Vector
ABC Elite Kit, followed by a reaction with either the Vector VIP peroxidase
substrate kit (Vector Laboratories, Burlingame, CA) or diaminobenzadine.
Labeled neurons were inspected using 40x and 100x objectives for
characteristic morphological features of different cell types described
previously by Farries and Perkel
(2002
). Soma area of each
recovered neuron was measured, from which soma diameter was estimated assuming
a spherical cell body.
 |
Results
|
|---|
Brain slices from 48 adult male zebra finches were used. On the basis of
criteria described in Materials and Methods
(Fig. 1), we were able to
distinguish SNs from other cell types in area X. Examples of an SN and a
non-SN type neuron are shown in Figure
2, A and B, respectively. The initial resting
potentials were -70 and -63 mV, respectively. In response to the standard
voltage ramp, putative SNs showed a distinct large inward current, peaking
first at approximately -30 mV and then again during the hyperpolarizing phase
of the ramp (Fig. 2A,
inset). Non-SNs responded with mostly outward current and occasional inward
inflections (Fig. 2B,
inset). When we plotted the ramp index against the initial resting potential
for all cells that we encountered, two clusters formed: one with more
hyperpolarized initial resting potentials and negative ramp indices, and one
with more depolarized initial resting potentials and positive ramp indices
(Fig. 2C).
Spontaneously active neurons appeared exclusively in the latter cluster. The
ratio of number of cells located in each cluster is consistent with the high
density of SNs and sparse distribution of cells of other types in area X
(Farries and Perkel, 2002
).
When recovered histologically, cells from the first cluster had smaller soma
diameters than those from the second cluster
(Fig. 2D). In
addition, spiny dendrites were found exclusively on cells from the first
cluster. We thus consider the first cluster as representing the SN class. In
this paper, only cells (n = 59) located within the first cluster,
i.e., with negative ramp indices, were used
(Fig. 2C, filled
circles).
To separate inputs from HVC and LMAN, we stimulated fibers as shown in
Figure 3A. The summary
of stimulation sites is shown in Table
1. The phenomena that we observed, as described below, do not seem
to depend on particular sites of stimulation. We therefore do not distinguish
HVC or LMAN inputs to area X in this paper.
As described previously (Farries,
2002
), at a positive holding potential, the late component of the
EPSC was abolished by 50 µM APV (Figs.
3B,
9D) (n = 11;
percentage reduction: 90 ± 10%). The remaining early component and
EPSCs evoked at -80 mV were blocked by 10 µM CNQX
(Fig. 3B) (n
= 19; percentage reduction: 93 ± 6%). Thus, the EPSC evoked at -80 mV
is mediated primarily by non-NMDA receptors, whereas the late component of the
EPSC evoked at positive potentials is mediated primarily by NMDA
receptors.

View larger version (32K):
[in this window]
[in a new window]
|
Figure 9. Forskolin does not reduce postsynaptic NMDA receptor function. A,
Direct pressure application of NMDA (2 mM) induced
voltage-sensitive current responses (puff response) in a spiny neuron. Note
the reversal potential at approximately +20 mV. B, In the same cell
shown in A, the currentvoltage plot of the puff response
showed voltage dependence similar to that of the late component of the EPSC
evoked with electrical stimulation. C, Summary plot of the change in
the puff response and the late component of the EPSC by forskolin application.
Filled symbols represent two cells where puffs and electrical stimulation were
interleaved, one of which is shown in D. D1,
Forskolin reduced the EPSC but not the puff response in a spiny neuron.
Subsequent application of APV blocked both the late component of EPSC and the
puff response. D2, Example traces of the EPSC.
D3, Example traces of the puff response. Holding
potential was +40 mV.
|
|
We found that SKF-38393, a D1-like DA receptor agonist, reduced both
non-NMDA and NMDA receptor-mediated EPSCs
(Fig. 4). At a holding
potential of -80 mV, 10 µM SKF-38393 caused a small but
significant decrease in the peak EPSC (Fig.
4A) (n = 8; two-tailed Wilcoxon ranked test;
p = 0.039) (Table 2). At positive holding potentials, SKF-38393 significantly and reversibly reduced
the peak as well as the late component of EPSCs
(Fig. 4B)(n =
20 for the late component; two-tailed Wilcoxon ranked test; p =
0.0002) (Table 2) and the
waveform scaled similarly, suggesting that both non-NMDA and NMDA
receptor-mediated components were affected. The percentage change in EPSC size
is comparable for non-NMDA and NMDA receptor-mediated components (Dunn's
multiple comparison test; p > 0.05). There was no significant
change in input resistance measured at either

View larger version (27K):
[in this window]
[in a new window]
|
Figure 4. SKF-38393 (10 µM) reduces ionotropic glutamatergic synaptic
responses in spiny neurons via activation of D1-like DA receptors.
A1, SKF-38393 reduced the amplitude of the
non-NMDA receptor-mediated EPSC. The numbers indicate the time when example
traces in A2 were taken.
A2, Example traces. Holding potential was -80 mV.
B1, SKF-38393 reversibly reduced the size of the
late component of the EPSC, which is mediated by NMDA receptors.
B2, Example traces. Holding potential was +70 mV.
C, SCH-23390 (1020 µM) blocked the effect of
SKF-38393, as shown in the summary plot of SKF-38393-induced percentage change
in EPSC size. Open circles represent non-NMDA receptor-mediated component
measured at a holding potential of -80 mV; filled circles represent NMDA
receptor-mediated component measured at positive holding potentials +30
+70 mV; open squares represent NMDA receptor-mediated component measured at
positive holding potentials in the presence of SCH-23390; filled diamonds
represent NMDA receptor-mediated component measured at positive holding
potentials in the presence of sulpiride (10 µM). Horizontal
lines indicate median values.
|
|
-80 mV or positive holding potentials (two-tailed Wilcoxon ranked test;
p = 0.5625 and 0.2397, respectively).
To test whether the observed effects were mediated by activation of D1-like
DA receptors, we applied SKF-38393 after a 10 min preincubation of SCH-23390,
a D1-like DA receptor antagonist. Because the reduction in non-NMDA and NMDA
receptor-mediated components seemed to be concurrent, we tested the effect of
SCH-23390 on EPSCs recorded at positive holding potentials and focused on the
NMDA receptor-mediated EPSC. We found that preincubation of SCH-23390
(1020 µM) blocked the effect of SKF-38393
(Fig. 4C) (n
= 5; Dunn's multiple comparison test; p < 0.01)
(Table 2). In contrast,
preincubation of sulpiride (10 µM), a D2-like DA receptor
antagonist, failed to block the effect of SKF-38393
(Fig. 4C) (n
= 3; Dunn's multiple comparison test; p > 0.05). These results
suggest that SKF-38393 suppresses NMDA receptor-mediated EPSCs by activating
D1-like DA receptors.
D1-like DA receptor activation triggers a G-protein-mediated signal cascade
that stimulates adenylyl cyclase and subsequently PKA
(Memo et al., 1986
). We next
tested whether this pathway was involved in inducing the effects of SKF-38393.
We first examined whether forskolin, a potent membrane-permeable adenylyl
cyclase activator, could mimic the depressing effects of SKF-38393. We found
that forskolin dramatically reduced both the non-NMDA and NMDA
receptor-mediated EPSCs (Fig.
5). At a holding potential of -80 mV, 10 µM
forskolin reversibly reduced peak EPSC amplitude
(Fig. 5A,C)
(n = 9; two-tailed Wilcoxon rank test; p = 0.0039)
(Table 2). At a positive
holding potential, forskolin also reversibly decreased the size of the late
component of EPSCs (Fig.
5B,C) (n = 18; two-tailed Wilcoxon rank test;
p = 0.0002) (Table 2).
Similar effects were also observed on the late EPSC size at negative holding
potentials (Fig.
5C)(n = 5), suggesting that the reduction is not
voltage dependent. The extent of the reduction is comparable for non-NMDA and
NMDA receptor-mediated components (Dunn's multiple comparison test; p
> 0.05). There was no significant change in input resistance measured at
either -80 mV or positive holding potentials (two-tailed Wilcoxon ranked test;
p = 0.4375 and 0.5417, respectively). The depression was not observed
with application of 0.1% DMSO alone (n = 3; data not shown),
confirming that it results from actions of forskolin itself.

View larger version (29K):
[in this window]
[in a new window]
|
Figure 5. Forskolin (FSK; 10 µM) mimics the synaptic depression induced
by SKF-38393. A1, FSK reversibly reduced the
amplitude of the non-NMDA receptor-mediated EPSC. The numbers indicate the
time when example traces in A2 were taken.
A2, Example traces. Holding potential was -80 mV.
B1, FSK reversibly reduced the size of the NMDA
receptor-mediated late component of the EPSC. B2,
Example traces. Holding potential was +40 mV. C, A similar depressing
effect of FSK was observed at various holding potentials, as shown in the
summary plot of FSK-induced percentage change in EPSC size. Open circles
represent non-NMDA receptor-mediated component measured at a holding potential
of -80 mV; filled triangles represent NMDA receptor-mediated component
measured at negative holding potentials between -40 and -20 mV; filled circles
represent NMDA receptor-mediated component measured at positive holding
potentials between +35 and +70 mV.
|
|
Forskolin has multiple effects on cellular properties, including
stimulating adenylyl cyclase activity
(Laurenza et al., 1989
). To
test whether the observed effects of forskolin indeed depended on adenylyl
cyclase activity, we performed similar experiments using 1,9-dideoxyforskolin,
an inactive forskolin analog that does not stimulate adenylyl cyclase. We
found that 1,9-dideoxyforskolin (10 µM) failed to change the
EPSCs, even in cells in which subsequent forskolin application induced a
significant reduction (Figs.
6A,C) (n = 5; Dunn's multiple comparison test;
p < 0.001) (Table
2). Furthermore, 10 min preincubation in 10 µM
Rp-cAMPS, a membrane-permeable inhibitor of cAMP-dependent protein kinase
activity, prevented the forskolin-induced suppression of EPSCs
(Fig. 6B,C)
(n = 7; Dunn's multiple comparison test; p < 0.001)
(Table 2). These results
indicate that forskolin reduces the EPSC by stimulating adenylyl cyclase
activity and subsequently activating the PKA pathway. We next tested whether
the PKA pathway also mediates the effect of SKF-38393. We found that
preincubation in Rp-cAMPS also blocked the SKF-38393-induced reduction in
EPSCs measured at positive holding potentials
(Fig. 6C,D)(n
= 11; Dunn's multiple comparison test; p < 0.01). Thus, SKF-38393
application reduces EPSCs by activating D1-like DA receptors and the PKA
pathway.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 6. The effects of SKF-38393 and forskolin are both mediated by the adenylyl
cyclasePKA pathway. A1,
1,9-dideoxyforskolin (DDF) failed to reduce the size of the NMDA
receptor-mediated late component of the EPSC, but forskolin (FSK) did reduce
this component. The numbers indicate the time when example traces in
A2 were taken. A2,
Example traces. Holding potential was +40 mV. B, Bath-applied
Rp-cAMPS (10 µM) blocked the effect of forskolin. Each symbol
represents the mean ± SEM of late EPSC size in a2 min window normalized
to the value before forskolin application. All data are from the same cell.
Filled circles represent forskolin application in the absence of Rp-cAMPS;
open squares represent subsequent forskolin application in the presence of
Rp-cAMPS after a 10 min preincubation in Rp-cAMPS.
C1, Bath-applied Rp-cAMPS (10 µM)
blocked the effect of SKF-38393. The numbers indicate the time when example
traces in C2 were taken. C2, Example
traces. Holding potential was +40 mV. D, Summary plot of forskolin or
SKF-38393-induced change in late EPSC size measured at positive holding
potentials between +30 and +70 mV.
|
|
These effects could be mediated presynaptically or postsynaptically, or
both. Activation of postsynaptic D1-like DA receptors enhances excitability in
SNs in area X in zebra finches (Ding and
Perkel, 2002
). Postsynaptic D1-like DA receptors could also
mediate the effects of SKF-38393 on EPSCs. Alternatively, given that both
non-NMDA and NMDA receptor-mediated responses were affected, a presynaptic
modulation of synaptic transmission is also conceivable. Because the PKA
pathway is required for the effects of SKF-38393, we chose to probe the two
possibilities with forskolin, because it is much more potent in activating the
PKA pathway. Positive findings obtained from forskolin were followed using
SKF-38393 to test whether similar conclusions could be drawn for activation of
D1-like DA receptors.
We first tested whether the reduction in EPSC is attributed to presynaptic
depression of transmitter release. A commonly used indicator for a reduction
in presynaptic transmitter release is an increase in the paired-pulse ratio
(Manabe et al., 1993
). We
found that forskolin raised the paired-pulse ratio
(Fig. 7A) (two-tailed
Wilcoxon rank test; p = 0.0078; also see example traces 2 and 3 in
Fig. 6A). Another
indication for a reduction in transmitter release is an increase in
coefficient of variation (CV) of the synaptic current amplitude
(del Castillo and Katz, 1954
;
Malinow and Tsien, 1990
),
which we also observed with forskolin application
(Fig. 7B) (two-tailed
Wilcoxon rank test; p < 0.0001). Thus, both measurements of
paired-pulse ratio and CV suggest that forskolin decreases presynaptic
transmitter release. To test whether the same held for activation of D1-like
DA receptors, we analyzed paired-pulse ratio and CV values of NMDA
receptor-mediated EPSCs with SKF-38393 application. As with forskolin,
SKF-38393 also significantly increased paired-pulse ratio and CV
(Fig. 7C,D)
(n = 11 and 20, p = 0.042 and 0.0014, respectively),
suggesting that activation of D1-like DA receptors reduces the EPSC by
decreasing presynaptic transmitter release. An additional commonly used test
for involvement of a presynaptic site of action is through analysis of
spontaneous EPSCs; we were unable to perform this test because area X SNs
receive very few spontaneous EPSCs.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 7. Paired-pulse ratio and coefficient of variation of EPSC amplitude increased
in the presence of forskolin (A, B) and SKF-38393 (C, D).
A, C, Scatter-plot of paired-pulse ratios before and during forskolin
and SKF-38393 application, respectively. Filled circles represent values
measured from late EPSC size at positive holding potentials; filled triangles
represent values from late EPSC size at negative holding potentials; open
circles represent values from EPSC amplitude at -80 mV; dashed line represents
a line with a slope of 1. Note that most data points lie above the line,
indicating an increase in paired-pulse ratio in the presence of
forskolin/SKF-38393. B, D, Scatter-plot of coefficients of variation
before and during forskolin and SKF-38393 application, respectively. Note that
most data points lie above the line.
|
|
To test whether postsynaptic mechanisms were also involved, we made
recordings with internal solutions containing 100400 µM
Rp-cAMPS. We have shown that bath-applied 10 µM Rp-cAMPS blocks
the effects of forskolin and SKF-38393
(Fig. 6). If intracellularly
applied Rp-cAMPS blocked or reduced these effects, then postsynaptic
PKA-mediated mechanisms must contribute to the overall reduction in EPSCs. If
the effects of forskolin and SKF-38393 were augmented instead, then activation
of the postsynaptic mechanisms alone may actually enhance EPSCs.
Alternatively, if forskolin and SKF-38393 continued to cause normal
depression, they likely act only at presynaptic sites. We tested our
predictions on the NMDA receptor-mediated EPSCs in six cells >20 min after
the initial access was obtained. Our results support the last prediction:
intracellular Rp-cAMPS did not alter the forskolin- or SKF-38393-induced
depression of the EPSCs (Fig.
8). In the presence of intracellular Rp-cAMPS, forskolin reduced
the late component of the EPSC by an average of 52%
(Fig. 8A,B,
Table 1) (n = 4),
whereas SKF-38393 reduced it by 16% (Fig.
8C,D, Table
1) (n = 5). The percentage changes induced by forskolin
or SKF-38393 were not different from those in the absence of intracellular
Rp-cAMPS (Dunn's multiple comparison tests; p > 0.05 for both
forskolin and SKF-38393), which is consistent with purely presynaptic
modulation by forskolin and SKF-38393.

View larger version (27K):
[in this window]
[in a new window]
|
Figure 8. Intracellularly applied Rp-cAMPS (100400 µM) does not
block the effects of forskolin and SKF-38393. A1,
Forskolin reduced the late EPSC size in the presence of intracellular
Rp-cAMPS. A2, Example traces. Holding potential
was +40 mV. B, Summary plot of change induced by forskolin. Rp-In,
Forskolin application in the presence of intracellularly applied Rp-cAMPS;
Rp-Ex, forskolin application in the presence of bath-applied Rp-cAMPS.
C1, In the same cell as in A, SKF-38393
also reduced the late EPSC size in the presence of intracellular Rp-cAMPS.
C2, Example traces. Holding potential was +40 mV.
D, Summary plot of percentage change induced by SKF-38393. Horizontal
lines indicate median values.
|
|
To explore further whether postsynaptic mechanisms contribute to forskolin
and D1-like DA receptor activation-induced reduction in the EPSC, we next
probed NMDA receptor function directly with pressure application of NMDA
(2100 mM) and examined whether forskolin reduces the
response to NMDA. The currentresponse to pressure-applied NMDA
("puffing") had the same voltage dependence as the late component
of EPSCs evoked electrically (Figs.
9A,B) (note similar enhanced responses at approximately
-20 mV and the same reversal potential for all responses). They also had
similar sensitivity to APV (Fig.
9D), confirming that the puff response was mediated by
NMDA receptors. In all six cells tested, forskolin failed to reduce responses
to the NMDA puff (Fig.
9C) (two-tailed Wilcoxon signed rank test; p =
0.8438). The percentage change in puff response ranged from -20 to 10%, with a
median value of 3%, significantly different from the percentage change in EPSC
size (Dunn's multiple comparison test; p < 0.001). Furthermore, in
two cells, puffs and electrical stimuli were interleaved during the same
forskolin application (Fig.
9C, filled symbols). In the cell shown in
Figure 9D, forskolin
had no effect on the puff response during its application, whereas it
significantly reduced the EPSC size during the same period. This is in clear
contrast to the APV-induced parallel decrease in both the EPSC size and puff
response. Thus, forskolin does not seem to suppress postsynaptic NMDA receptor
functions.
Taken together, these data suggest that the SKF-38393 and forskolin-induced
depression in EPSCs is mediated by a presynaptic site of action. Presynaptic
depression could result from activation of presynaptic D1-like DA receptors
or, alternatively, from actions of a diffusible messenger released in response
to SKF-38393 or forskolin. We next tested whether adenosine, GABA, or
endocannabinoids could serve as such a messenger, as reported at other
glutamatergic synapses (Dolphin and
Prestwich, 1985
; Dunwiddie and
Haas, 1985
; Dutar and Nicoll,
1988
; Shen et al.,
1996
). We found that preincubation of 500 nM DPCPX, an
adenosine A1 receptor antagonist, completely abolished the depressing effect
of forskolin (Fig.
10A,B) (n = 5; Dunn's multiple comparison test;
p < 0.01), whereas 500 µM CGP-35348, a
GABAB receptor antagonist, or 45 µM AM-251, a
cannabinoid CB1 receptor antagonist, had no effect
(Fig. 10B)
(n = 2 and 3, respectively), suggesting that activation of adenosine
receptors mediates forskolin-induced presynaptic depression.

View larger version (17K):
[in this window]
[in a new window]
|
Figure 10. A, The adenosine A1 receptor antagonist DPCPX (500 nM)
blocked forskolin-induced synaptic depression. Inset, Example traces of EPSCs.
Holding potential was -80 mV. B, Summary plot of the change in EPSC
size by forskolin application in the presence of CGP35348 (CGP; 500
µM), AM251 (AM; 45 µM), or DPCPX (500
nM). Data points labeled "NMDA" and "CGP"
were measured from the late component of EPSCs at positive holding potentials,
whereas the others were from EPSC sizes recorded at a holding potential of -80
mV.
|
|
In a small subset of cells, we also observed a much-delayed potentiation
(Fig. 11) (n = 3 of
11). In the example shown in Figure
9D, an enhancement of both the EPSC size and puff
response developed
25 min after forskolin was washed out of the bath.
This suggests that forskolin may trigger delayed potentiation of postsynaptic
NMDA receptor functions. However, given the infrequent occurrence of this
phenomenon, we did not pursue it further in this study.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 11. In a subset of neurons, forskolin induced delayed potentiation in the NMDA
receptor-mediated EPSC. In 3 of 11 cells, the late EPSC size increased 20
min after forskolin was washed out of the bath. Lines connect data points
measured from the same cells.
|
|
 |
Discussion
|
|---|
We have shown that activation of D1-like DA receptors reduces non-NMDA and
NMDA glutamate receptor-mediated synaptic transmission onto SNs in area X of
the adult zebra finch. This modulation involves the adenylyl cyclasePKA
pathway and requires a presynaptic site of action. Combined with our previous
results on excitability, these effects suggest that DA can exert complex
control on the signal transformation of excitatory inputs from HVC and
LMAN.
Several pieces of evidence indicate that the D1-like DA receptor-mediated
reduction results from depression of presynaptic transmitter release and does
not require postsynaptic modulation of receptor function: (1) both non-NMDA
and NMDA receptor-mediated synaptic currents are reduced to a similar extent;
(2) the reduction is associated with increased paired-pulse ratio and
coefficient of variation; (3) bath-applied, but not intracellular, Rp-cAMPS
blocks the reduction; and (4) the response to application of exogenous NMDA is
not reduced by forskolin, even in cells in which EPSCs are significantly
depressed. Thus, a presynaptic site of action is required for the depressing
effects of D1-like DA agonist and forskolin.
A priori, presynaptic depression could be achieved either by
activation of D1-like DA receptors on the presynaptic terminals or through an
intermediary diffusible messenger that inhibits presynaptic transmitter
release. Our data showing that the adenosine A1 receptor antagonist completely
abolished the forskolin-induced reduction in EPSC size
(Fig. 10) strongly suggest
that such presynaptic depression is mediated by adenosine as an intermediary
messenger. Two pieces of evidence further constrain the mechanism for D1-like
DA receptor agonist or forskolin-induced adenosine release. Because forskolin
failed to reduce EPSC size in the presence of the adenosine A1 receptor
antagonist, adenosine release and subsequent activation of adenosine receptors
are most likely downstream from activation of PKA. Because the reduction in
the EPSC was not blocked by intracellularly applied Rp-cAMPS
(Fig. 8), homosynaptic
adenosine release seems unlikely to be the major contributor. Taken together,
these results are most consistent with the scenario shown in
Figure 12. Briefly, activation
of D1-like DA receptors triggers a second-messenger cascade that stimulates
PKA activity, which leads to adenosine release from cellular elements other
than the postsynaptic neuron being recorded; however, these could be other
area X SNs. Adenosine then binds to adenosine A1 receptors at the presynaptic
terminals, the activation of which induces inhibition of presynaptic glutamate
release. A D1-like DA receptor and adenosine-mediated presynaptic depression
has also been reported in the ventral tegmental area of guinea pigs
(Bonci and Williams, 1996
).

View larger version (17K):
[in this window]
[in a new window]
|
Figure 12. Hypothesized mechanism underlying the D1-like DA receptor-mediated
presynaptic depression. A, Adenosine; AC, adenylyl cyclase; AR,
adenosine receptor; D1R, D1-like DA receptors. Solid lines indicate
activation. Dashed lines indicate release/diffusion/binding. See Discussion
for more details.
|
|
Because adenosine is diffusible and because these effects involve adenosine
release possibly from multiple sources, the specificity of the synaptic
depression, i.e., which inputs are reduced, is determined primarily by
diffusion range of adenosine and selective expression of the presynaptic
adenosine receptors, rather than by selective expression of presynaptic DA
receptors. In other words, the synaptic depression would not necessarily be
specific to a given glutamatergic synapse and could affect active and passive
pathways alike, thereby providing general inhibition of afferent signals from
HVC and LMAN.
Interestingly, when compared with observations in the mammalian striatum,
the presynaptic depression in area X of zebra finch is similar to the
depression phenomenon reported in the nucleus accumbens. We observed a
PKA-dependent and adenosine-dependent presynaptic depression. In the core and
shell region of nucleus accumbens, activation of D1-like DA receptors also
induces presynaptic depression of glutamatergic transmission
(Pennartz et al., 1992
;
Harvey and Lacey, 1996
;
Nicola et al., 1996
). Harvey
and Lacey (1997
) further
demonstrated that this depression is mediated via adenosine release. However,
although the detailed mechanisms are still controversial, the current
consensus suggests that the effect of D1-like DA receptor activation does not
require the PKA pathway in mammalian nucleus accumbens.
It is also worth noting that we observed a forskolin-induced delayed
potentiation in the NMDA receptor-mediated response in a small subset of area
X spiny neurons (Fig. 11),
similar to that reported in mammalian dorsal striatum
(Colwell and Levine, 1995
). In
the dorsal striatum, the main reported effect of D1-like DA receptor agonist
and forskolin is potentiation of postsynaptic glutamate receptors
(Cepeda et al., 1993
;
Levine et al., 1996
;
Umemiya and Raymond, 1997
;
Price et al., 1999
;
Snyder et al., 2000
), with the
effect on non-NMDA EPSCs being less consistent
(Cepeda et al., 1993
;
Levine et al., 1996
). However,
forskolin-induced early-onset depression has also been observed in mammalian
dorsal striatum (Colwell and Levine,
1995
, their Fig.
1). Thus, it is possible that there are two types of spiny neurons
in area X and possibly the mammalian striatum, one of which responds to
forskolin with enhanced postsynaptic response in addition to the nonspecific
presynaptic depression. Alternatively, the effects of PKA and D1-like DA
receptor activation are region/synapse-specific, an idea further supported by
the observed facilitation of transmitter release by PKA and D1-like DA
receptor activation in rat hippocampus
(Trudeau et al., 1996
) and
substantia nigra pars reticulata (Radnikow
and Misgeld, 1998
), respectively, and D1-like DA receptor-mediated
presynaptic depression in prefrontal cortex
(Gao et al., 2001
). Such
region/synapse specificity implies that the functional roles of DA and PKA may
also differ among different brain regions.
Given that most of the glutamatergic synapses tested in area X exhibit
presynaptic depression in response to D1-like DA receptors, the same direction
of change as in mammalian nucleus accumbens rather than in dorsal striatum, it
seems possible that area X processes the pallial inputs in ways specific to
more cognitive/motivational signals. Area X clearly has sensorimotor
functions, because it is required for vocal learning in juvenile birds
(Scharff and Nottebohm, 1991
),
but in contrast to dramatic movement disorders often caused by malfunctioning
of the basal ganglia in mammals
(Denny-Brown, 1962
), lesions
in area X do not affect normal song production or other motor behaviors in
adult zebra finches (Scharff and
Nottebohm, 1991
). In addition, the properties of neural activity
in area X, probed with immediate-early gene expression
(Jarvis et al., 1998
) or with
in vivo extracellular recordings
(Hessler and Doupe, 1999
),
vary considerably with different social contexts. These results suggest that
area X functions are likely also cognitive and limbic, rather than strictly
motor. Conceivably, both cognitive and sensorimotor information is processed
in area X, and the variation in forskolin/dopamine effects may reflect this
distinction.
To explore this idea further and, more importantly, to get a better
understanding of dopamine functions in the song system, it is necessary to
continue teasing apart the effects of dopamine on other aspects of area X
physiology, such as possible D2-like DA receptor modulation of glutamatergic
synaptic transmission, dopamine modulation of inhibitory synaptic transmission
and plasticity, and cellular localization of DA receptors, etc. Results
obtained under carefully and systematically controlled conditions and on
single aspects of area X physiology can then be integrated and serve as the
foundation for elucidating the role of dopamine in the vocal behavior of
songbirds and lend more general insights into dopamine function in
vertebrates.
 |
Footnotes
|
|---|
Received Mar. 25, 2003;
revised May. 8, 2003;
accepted May. 9, 2003.
We thank members of the Perkel lab for valuable discussions and comments on
this manuscript. D.J.P. is an affiliate of the Virginia Merrill Bloedel
Hearing Research Center. This work was supported by grants to D.J.P. from
National Institutes of Health (NIH) (R01-MH56646) and National Science
Foundation (IBN0196104), NIH/National Institute of Deafness and Other
Communication Disorders P30 Core Grant DC04661, and National Research Service
Award MH12640 to M.A.F.
Correspondence should be addressed to David Perkel, Departments of Biology
and Otolaryngology, University of Washington, Box 356515, 1959 NE Pacific
Street, HSB BB1148, Seattle, WA 98195-6515. E-mail:
perkel{at}u.washington.edu.
Copyright © 2003 Society for Neuroscience
0270-6474/03/236086-10$15.00/0
 |
References
|
|---|
Blanton MG, Lo Turco JJ, Kriegstein AR (1989) Whole
cell recording from neurons in slices of reptilian and mammalian cerebral
cortex. J Neurosci Methods 30:
203210.[Web of Science][Medline]
Bonci A, Williams JT (1996) A common mechanism
mediates long-term changes in synaptic transmission after chronic cocaine and
morphine. Neuron 16:
631639.[Web of Science][Medline]
Bottjer SW (1993) The distribution of tyrosine
hydroxylase immunoreactivity in the brains of male and female zebra finches.
J Neurobiol 24:
5169.[Web of Science][Medline]
Bottjer SW, Johnson F (1997) Circuits, hormones, and
learning: vocal behavior in songbirds. J Neurobiol
33: 602618.[Web of Science][Medline]
Bottjer SW, Miesner EA, Arnold AP (1984) Forebrain
lesions disrupt development but not maintenance of song in passerine birds.
Science 224:
901903.[Abstract/Free Full Text]
Bottjer SW, Halsema KA, Brown SA, Miesner EA (1989)
Axonal connections of a forebrain nucleus involved with vocal learning in
zebra finches. J Comp Neurol 279:
312326.[Web of Science][Medline]
Brainard MS, Doupe AJ (2000) Interruption of a basal
ganglia-forebrain circuit prevents plasticity of learned vocalizations.
Nature 404:
762766.[Medline]
Brown LL, Schneider JS, Lidsky TI (1997) Sensory and
cognitive functions of the basal ganglia. Curr Opin Neurobiol
7: 157163.[Web of Science][Medline]
Cepeda C, Buchwald NA, Levine MS (1993)
Neuromodulatory actions of dopamine in the neostriatum are dependent upon the
excitatory aminoacid receptor subtypes activated. Proc Natl Acad Sci
USA 90:
95769580.[Abstract/Free Full Text]
Colwell CS, Levine MS (1995) Excitatory synaptic
transmission in neostriatal neurons: regulation by cyclic AMP-dependent
mechanisms. J Neurosci 15:
17041713.[Abstract]
del Castillo J, Katz B (1954) Quantal components of
the end-plate potential. J Physiol (Lond)
124:
560573.
Denny-Brown D (1962) The basal ganglia, and
their relation to disorders of movement. London: Oxford
UP.
Ding L, Perkel DJ (2002) Dopamine modulates
excitability of spiny neurons in the avian basal ganglia. J
Neurosci 22:
52105218.[Abstract/Free Full Text]
Dolphin AC, Prestwich SA (1985) Pertussis toxin
reverses adenosine inhibition of neuronal glutatmate release.
Nature 316:
148150.[Medline]
Dunwiddie TV, Haas HL (1985) Adenosine increases
synaptic facilitation in the in vitro rat hippocampus: evidence for a
presynaptic site of action. J Physiol (Lond)
369:
365377.[Abstract/Free Full Text]
Dutar P, Nicoll RA (1988) A physiological role for
GABAB receptors in the central nervous system.
Nature 332:
156158.[Medline]
Farries MA (2002) Organization and
electrophysiological properties of an avian basal ganglia structure essential
for song learning. PhD thesis, University of
Pennsylvania.
Farries MA, Perkel DJ (2002) A telencephalic nucleus
essential for song learning contains neurons with physiological
characteristics of both striatum and globus pallidus. J
Neurosci 22:
37763787.[Abstract/Free Full Text]
Gao W-J, Krimer LS, Goldman-Rakic PS (2001)
Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal
circuits. Proc Natl Acad Sci USA 98:
295300.[Abstract/Free Full Text]
Graybiel AM, Aosaki T, Flaherty AW, Kimura M (1994)
The basal ganglia and adaptive motor control. Science
265:
18261831.[Abstract/Free Full Text]
Harvey J, Lacey MG (1996) Endogenous and exogenous
dopamine depress EPSCs in rat nucleus accumbens in vitro via D1
receptor activation. J Physiol (Lond)
492:
143154.[Abstract/Free Full Text]
Harvey J, Lacey MG (1997) A postsynaptic interaction
between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the
rat nucleus accumbens via adenosine release. J Neurosci
17:
52715280.[Abstract/Free Full Text]
Hessler NA, Doupe AJ (1999) Social context modulates
singing-related neural activity in the songbird forebrain. Nat
Neurosci 2:
209211.[Web of Science][Medline]
Jarvis ED, Scharff C, Grossman MR, Ramos JA, Nottebohm F
(1998) For whom the bird sings: context-dependent gene
expression. Neuron 21:
775788.[Web of Science][Medline]
Laurenza A, Sutkowski EM, Seamon KB (1989) Forskolin:
a specific stimulator of adenylyl cyclase or a diterpene with multiple sites
of action. Trends Pharmacol Sci 10:
442447.[Medline]
Levine MS, Li ZW, Cepeda C, Cromwell HC, Altemus KL
(1996) Neuromodulatory actions of dopamine on synaptically-evoked
neostriatal responses in slices. Synapse
24: 6578.[Web of Science][Medline]
Lewis JW, Ryan SM, Arnold AP, Butcher LL (1981)
Evidence for a catecholaminergic projection to area X in the zebra finch.
J Comp Neurol 196:
347354.[Web of Science][Medline]
Luo M, Ding L, Perkel DJ (2001) An avian basal ganglia
pathway essential for vocal learning forms a closed topographic loop. J
Neurosci 21:
68366845.[Abstract/Free Full Text]
Malinow R, Tsien RW (1990) Presynaptic enhancement
shown by whole-cell recordings of long-term potentiation in hippocampal
slices. Nature 346:
177180.[Medline]
Manabe T, Wyllie DJ, Perkel DJ, Nicoll RA (1993)
Modulation of synaptic transmissionand long-term potentiation:effects on
paired pulse facilitation and EPSC variance in the CA1 region of the
hippocampus. J Neurophysiol 70:
14511459.[Abstract/Free Full Text]
Memo M, Missale C, Carruba MO, Spano PF (1986)
Pharmacology and biochemistry of dopamine receptors in the central nervous
system and peripheral tissue. J Neural Transm [Suppl]
22: 1932.
Nicola SM, Kombian SB, Malenka RC (1996)
Psychostimulants depress excitatory synaptic transmission in the nucleus
accumbens via presynaptic D1-like dopamine receptors. J
Neurosci 16:
15911604.[Abstract/Free Full Text]
Pennartz CMA, Dollemanvanderweel MJ, Kitai ST, Dasilva FHL
(1992) Presynaptic dopamine D1 receptors attenuate excitatory and
inhibitory limbic inputs to the shell region of the rat nucleus accumbens
studied in vitro. J Neurophysiol
67:
13251334.[Abstract/Free Full Text]
Price CJ, Kim P, Raymond LA (1999) D1 dopamine
receptor-induced cyclic AMP-dependent protein kinase phosphorylation and
potentiation of striatal glutamate receptors. J Neurochem
73:
24412446.[Web of Science][Medline]
Radnikow G, Misgeld U (1998) Dopamine D1 receptors
facilitate GABAA synaptic currents in the rat substantia nigra pars
reticulata. J Neurosci 18:
20092016.[Abstract/Free Full Text]
Reiner A, Medina L, Veenman CL (1998) Structural and
functional evolution of the basal ganglia in vertebrates. Brain Res
Rev 28:
235285.[Medline]
Scharff C, Nottebohm F (1991) A comparative study of
the behavioral deficits following lesions of various parts of the zebra finch
song system: implications for vocal learning. J Neurosci
11:
28962913.[Abstract]
Schultz W (1998) Predictive reward signal of dopamine
neurons. J Neurophysiol 80:
127.[Abstract/Free Full Text]
Shen M, Piser TM, Seybold VS, Thayer SA (1996)
Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in
rat hippocampal cultures. J Neurosci 16:
43224334.[Abstract/Free Full Text]
Snyder GL, Allen PB, Fienberg AA, Valle CG, Huganir RL, Nairn AC,
Greengard P (2000) Regulation of phosphorylation of the GluR1
AMPA receptor in the neostriatum by dopamine and psychostimulants in
vivo. J Neurosci 20:
44804488.[Abstract/Free Full Text]
Soha JA, Shimizu T, Doupe AJ (1996) Development of the
catecholaminergic innervation of the song system of the male zebra finch.
J Neurobiol 29:
473489.[Web of Science][Medline]
Sohrabji F, Nordeen EJ, Nordeen KW (1990) Selective
impairment of song learning following lesions of a forebrain nucleus in the
juvenile zebra finch. Behav Neural Biol
53: 5163.[Web of Science][Medline]
Stark LL, Perkel DJ (1999) Two-stage, input-specific
synaptic maturation in a nucleus essential for vocal production in the zebra
finch. J Neurosci 19:
91079116.[Abstract/Free Full Text]
Trudeau L-E, Emery DG, Haydon PG (1996) Direct
modulation of the secretory machinery underlies PKA-dependent synaptic
facilitation in hippocampal neurons. Neuron
17: 789797.[Web of Science][Medline]
Umemiya M, Raymond LA (1997) Dopaminergic modulation
of excitatory postsynaptic currents in rat neostriatal neurons. J
Neurophysiol 78:
12481255.[Abstract/Free Full Text]
Vates GE, Nottebohm F (1995) Feedback circuitry within
a song-learning pathway. Proc Natl Acad Sci USA
92:
51395143.[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
J. A. Varela, S. J. Hirsch, D. Chapman, L. S. Leverich, and R. W. Greene
D1/D5 Modulation of Synaptic NMDA Receptor Currents
J. Neurosci.,
March 11, 2009;
29(10):
3109 - 3119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Kao, B. D. Wright, and A. J. Doupe
Neurons in a Forebrain Nucleus Required for Vocal Plasticity Rapidly Switch between Precise Firing and Variable Bursting Depending on Social Context
J. Neurosci.,
December 3, 2008;
28(49):
13232 - 13247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, P. Deng, Y. Ruan, and Z. C. Xu
Dopamine D1-Like Receptors Depress Excitatory Synaptic Transmissions in Striatal Neurons After Transient Forebrain Ischemia
Stroke,
August 1, 2008;
39(8):
2370 - 2376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Gale and D. J. Perkel
Physiological Properties of Zebra Finch Ventral Tegmental Area and Substantia Nigra Pars Compacta Neurons
J Neurophysiol,
November 1, 2006;
96(5):
2295 - 2306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sasaki, T. D. Sotnikova, R. R. Gainetdinov, and E. D. Jarvis
Social context-dependent singing-regulated dopamine.
J. Neurosci.,
August 30, 2006;
26(35):
9010 - 9014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Cragg
Singing to the Tune of Dopamine. Focus on "Properties of Dopamine Release and Uptake in the Songbird Basal Ganglia"
J Neurophysiol,
April 1, 2005;
93(4):
1827 - 1828.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Gale and D. J. Perkel
Properties of Dopamine Release and Uptake in the Songbird Basal Ganglia
J Neurophysiol,
April 1, 2005;
93(4):
1871 - 1879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ding and D. J. Perkel
Long-Term Potentiation in an Avian Basal Ganglia Nucleus Essential for Vocal Learning
J. Neurosci.,
January 14, 2004;
24(2):
488 - 494.
[Abstract]
[Full Text]
[PDF]
|
 |
|